Switch to:
More From Other Websites
Here’s Why Novartis Is Expected To See Soaring Top-Line Growth May 29 2015
How to Trade 5 Big Stocks for Big Gains -- Must-See Charts May 29 2015
Helping your own immune system fight cancer May 28 2015
Early movers: TIF, KORS, TOL, BWS, HRL & more May 27 2015
Novartis digs into health tech with bet on "robotic pill" May 27 2015
Novartis digs into health tech with bet on 'robotic pill' May 27 2015
Novartis digs into health tech with bet on "robotic pill" May 27 2015
Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA » May 27 2015
Pharma Trumps All Healthcare Sectors In Executive Compensation May 26 2015
Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog May 22 2015
Novartis' Summer Blockbuster LCZ696 Gains A Name, Skips An Advisory Panel May 22 2015
Novartis drug Afinitor® extended progression-free survival in Phase III trial in advanced... May 21 2015
Novartis announces two positive US phase III programs in COPD for QVA149 and NVA237 » May 20 2015
Buckingham's Top Four New Buys of First Quarter Go Up in Price May 15 2015
Why Clovis is Getting Clobbered May 15 2015
Is Sir Andrew Witty The Person To Lead A Major Pharmaceutical Company? May 14 2015
Possible Investment Contest May 13 2015
GSK's Curious Oncology Research Position -- A Recipe For Failure? May 12 2015
Novartis' Zykadia Approved in the EU for Lung Cancer - Analyst Blog May 11 2015
​Amgen wins injunction against Novartis' biosimilar drug May 08 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK